Authors
Loading...
Preclinical study demonstrates rosiglitazone enhances insulin-induced glucose uptake via PKC-zeta/lambda activation in rat adipocytes, highlighting a mechanism for improving insulin action.
Kanoh et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: